323 related articles for article (PubMed ID: 18815107)
1. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease].
Juhász M; Tulassay Z
Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
3. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
Labenz J; Labenz G; Stephan D; Willeke F;
MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
[TBL] [Abstract][Full Text] [Related]
4. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
5. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
6. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
7. Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.
Goh KL; Choi MG; Hsu WP; Chun HJ; Mahachai V; Kachintorn U; Leelakusolvong S; Kim N; Rani AA; Wong BC; Wu J; Chiu CT; Chu R; Shetty V; Bocobo JC; Chan MM; Lin JT
J Gastroenterol Hepatol; 2014 Dec; 29(12):1969-75. PubMed ID: 24990817
[TBL] [Abstract][Full Text] [Related]
8. Refractory gastrooesophageal reflux disease.
Bredenoord AJ; Smout AJ
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
10. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease.
Hershcovici T; Jha LK; Gadam R; Cui H; Gerson L; Thomson S; Fass R
J Clin Gastroenterol; 2012 Sep; 46(8):662-8. PubMed ID: 22858518
[TBL] [Abstract][Full Text] [Related]
11. Noncompliance is an impact factor in the treatment of gastroesophageal reflux disease.
Domingues G; Moraes-Filho JP
Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):761-5. PubMed ID: 24754402
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
Frazzoni L; Fuccio L; Frazzoni M
Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
[TBL] [Abstract][Full Text] [Related]
14. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
Woodland P; Sifrim D
Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
18. Refractory gastroesophageal reflux disease: advances and treatment.
Ates F; Francis DO; Vaezi MF
Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):657-67. PubMed ID: 24745809
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
